Immunohistochemical Scores for Programmed Death Ligand-1 (PD-L1) Expression and Prognostic in Patients with Gastric Cancer

被引：0
|
作者：
Pereira, Marina A. [1 ]
Ramos, Marcus Fernando Kodama P. [1 ]
Ribeiro e Ribeiro, Renan [1 ]
Dias, Andre R. [1 ]
Ribeiro, Ulysses, Jr. [1 ]
Zilberstein, Bruno [1 ]
Cecconello, Ivan [1 ]
Mello, Evandro Sobroza [1 ]
Castria, Tiago B. [1 ]
机构：
[1] Univ Sao Paulo, Fac Med, Hosp Clin, Inst Canc, Sao Paulo, Brazil
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2020年 / 231卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：E208 / E208
页数：1
相关论文
共 50 条
  • [31] Programmed cell death ligand-1(PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
    Mari Mino-Kenudson
    Cancer Biology & Medicine, 2016, (02) : 157 - 170
  • [32] Programmed death receptor ligand-1 (PD-L1) expression in a thymoma (T) tissue microarray (TMA)
    Padda, Sukhmani Kaur
    Riess, Jonathan
    Schwartz, Erich Jurgen
    Tian, Lu
    Kohrt, Holbrook Edwin
    Neal, Joel W.
    Natkunam, Yasodha
    West, Robert B.
    Wakelee, Heather A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] HER2 and programmed deatb-1 ligand-1 (PD-L1) expression in gastric carcinoma
    Oki, Eiji
    Okano, Shinji
    Ando, Koji
    Hiyoshi, Yukiharu
    Ito, Shuhei
    Morita, Maseru
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Obesity and lung cancer - is programmed death ligand-1 (PD-1L) expression a connection?
    Galazka, Jakub Krzysztof
    Czeczelewski, Marcin
    Kucharczyk, Tomasz
    Szklener, Katarzyna
    Mandziuk, Slawomir
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (01) : 313 - 316
  • [35] Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types
    Scognamiglio, Giosue
    De Chiara, Anna
    Di Bonito, Maurizio
    Tatangelo, Fabiana
    Losito, Nunzia Simona
    Anniciello, Annamaria
    De Cecio, Rossella
    D'Alterio, Crescenzo
    Scala, Stefania
    Cantile, Monica
    Botti, Gerardo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)
  • [36] Clinical significance of programmed death ligand-1 (PD-L1) in colorectal serrated adenocarcinoma
    Zhu, Hailong
    Qin, Huali
    Huang, Ziling
    Li, Shuai
    Zhu, Xuyou
    He, Jian
    Yang, Jing
    Yu, Xiaoting
    Yi, Xianghua
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (08): : 9351 - 9359
  • [37] Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors
    Zhang, Lin
    Qiu, Miaozhen
    Jin, Ying
    Ji, Jiao
    Li, Baoxia
    Wang, Xueping
    Yan, Shumei
    Xu, Ruihua
    Yang, Dajun
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (09): : 11084 - 11091
  • [38] Prognostic significance of programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in uterine carcinosarcoma
    Gulec, Umran Kucukgoz
    Bagir, Emine Kilic
    Paydas, Semra
    Guzel, Ahmet Baris
    Gumurdulu, Derya
    Vardar, Mehmet Ali
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 244 : 51 - 55
  • [39] Prognostic value of programmed death-ligand 1 (PD-L1) expression in patients with stage III colorectal cancer.
    Koganemaru, Shigehiro
    Inoshita, Naoko
    Miura, Yuji
    Fukui, Yudai
    Ozaki, Yukinori
    Tomizawa, Kenji
    Hanaoka, Yutaka
    Toda, Shigeo
    Suyama, Koichi
    Tanabe, Yuko
    Moriyama, Jin
    Fujii, Takeshi
    Matoba, Shuichiro
    Kuroyanagi, Hiroya
    Takano, Toshimi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer
    Govindarajan, Rangaswamy
    Gujja, Swetha
    Siegel, Eric R.
    Batra, Anu
    Saeed, Anwaar
    Lai, Keith
    James, Jennifer D.
    Fogel, Bradley J.
    Williamson, Stephen
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (07): : 638 - 642
12345